CCL2 and chronic kidney disease: In particular, ESKD patients had signifcantly higher levels of IFN-γ, TNF-α, sCD40L, GM-CSF, IL-4, IL-8, MCP-1, and MIP-1β than CKD patients (Figure 1; Supplementary Figure 1).